Female Viagra (Sildenafil 100mg, Off-Label)
Female Viagra is a marketing name for sildenafil citrate 100mg tablets sold for women through international online pharmacies. The product is not FDA-approved for female use and is positioned off-label, despite the popular name.
- Active ingredients
- Sildenafil Citrate
- Manufacturer
- Various generics
- Dosage forms
- tablet
- Available dosages
- 100mg
- Category
- Women's Sexual Health
What is it?
Female Viagra is a marketing label used by international online pharmacies for sildenafil citrate 100mg tablets sold to women, typically in pink film-coated form. Despite the name, the product is not approved by the FDA, EMA or other major regulators for the treatment of female sexual dysfunction. The active ingredient, sildenafil citrate, is the same molecule used in standard Viagra; manufacturers vary, and the regulatory status of any specific batch depends on local registration.
Active ingredients
Each tablet contains 100mg of sildenafil citrate, the same selective PDE5 inhibitor used for erectile dysfunction in men. The pharmacological mechanism — increasing genital blood flow through cGMP accumulation — is theoretically applicable to women, since PDE5 is also present in female genital tissue. However, controlled trials of sildenafil for female sexual arousal disorder have shown mixed and inconsistent results, and the molecule has not received approval for any female sexual indication.
Forms and dosages
Female Viagra is supplied as 100mg film-coated tablets, often pink in colour to differentiate from standard Viagra. International online pharmacies typically recommend one tablet 30 to 60 minutes before planned sexual activity, with a maximum of one dose per 24 hours. Because there is no approved indication, no formal dosing schedule applies. Women considering use should consult a healthcare provider; lower doses of sildenafil have been used in some clinical research.
Indications
Female Viagra has no approved indication. Major regulators have not authorised sildenafil for any female sexual dysfunction. The FDA-approved options for hypoactive sexual desire disorder in premenopausal women are flibanserin (Addyi) and bremelanotide (Vyleesi), which work through different mechanisms. According to clinical guidelines, off-label use of sildenafil by women should not be undertaken without medical supervision.
How it works
Sildenafil citrate inhibits PDE5, allowing cGMP to accumulate in vascular smooth muscle and increasing local blood flow during arousal. In men this supports erection; in women, the theory is that increased genital blood flow could improve arousal and lubrication. Clinical trials in women have produced inconsistent results and no major regulator has accepted the evidence for approval. Sexual stimulation is required for any expected effect, and the molecule does not act on desire.
Frequently asked questions
Is Female Viagra FDA-approved? ▾
No. Despite the marketing name, sildenafil citrate has no FDA approval for any female sexual indication. The two FDA-approved treatments for hypoactive sexual desire disorder in premenopausal women are flibanserin (Addyi) and bremelanotide (Vyleesi). Sildenafil-based products sold as Female Viagra are off-label and unauthorised for female use, regardless of how they are marketed by international online pharmacies.
Does Female Viagra actually work for women? ▾
Clinical trial evidence is mixed. Some studies have reported modest improvements in genital arousal and lubrication in women with arousal disorder, while others have shown no significant benefit over placebo. Sildenafil does not act on sexual desire and is unlikely to help with hypoactive sexual desire disorder, which is a desire problem rather than a blood-flow problem. According to current guidelines, the evidence does not support routine prescription.
What is the difference between Female Viagra and Addyi? ▾
Female Viagra contains sildenafil citrate, a PDE5 inhibitor taken on demand to support genital blood flow. Addyi (flibanserin) is a serotonin-dopamine modulator taken daily that targets sexual desire pathways in the central nervous system. The two work through entirely different mechanisms. Addyi is FDA-approved for hypoactive sexual desire disorder in premenopausal women; Female Viagra is not approved for any female indication.
Are there safety concerns specific to women? ▾
The contraindications of sildenafil — particularly use with nitrates and severe cardiovascular disease — apply to women just as to men. In addition, there is limited safety data in pregnancy, breastfeeding and in postmenopausal women. According to general prescribing principles for sildenafil, women should not use the molecule without medical supervision, and online-only purchase from unverified sources adds further risk of counterfeit material.
What evidence-based options exist for female sexual concerns? ▾
Evidence-based options include FDA-approved medications for hypoactive sexual desire disorder (flibanserin, bremelanotide), hormone therapy in postmenopausal women, cognitive-behavioral therapy, couples counselling and treatment of any underlying medical or psychiatric conditions. According to clinical guidelines, evaluation by a qualified clinician — gynaecologist, urologist, or sexual medicine specialist — should precede any pharmacological treatment.
Related medications
The information on this website is provided for reference and educational purposes only. It does not replace consultation with a qualified healthcare professional.